SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (915)4/5/2000 8:03:00 AM
From: Jim Oravetz  Respond to of 52153
 
SCHAUMBURG, Ill., April 4 /PRNewswire/ -- Motorola, Inc. (NYSE: MOT) announced today that it has made a strategic equity investment in TissueInformatics.Inc, a privately held, Pittsburgh-based bioinformatics company that is building the world's first Virtual Tissue Banks(TM). Under the terms of the agreement, Motorola and TissueInformatics will also work toward a two-way technology transfer agreement. SNIP....

prnewswire.com

Jim



To: Jim Oravetz who wrote (915)4/5/2000 9:21:00 AM
From: nigel bates  Respond to of 52153
 
Thanks Jim,

you (& Burrill) just saved me a lot of work this weekend.

nig



To: Jim Oravetz who wrote (915)4/5/2000 11:19:00 AM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Thanks, Jim. Actually, that Burrill list seems to be missing some stuff - in particular some private equity placements - e.g., PCYC's $60 million sale of common.

In fact I've seen a $15 billion number for the quarter, of which about $13 billion was by existing public companies (the balance was IPO's and VC funding).

Peter



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News